JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 4. Box plot showing normalized uptake (cps/administered MBq) by 21 breast cancers in 21 women examined with 99mTc-exametazime and 99mTc-sestamibi. Wilcoxon matched-pairs test showed no significant difference between the 2 tracers (P = 0.48). HMPAO = exametazime; MIBI = sestamibi.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE